Efficacy of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC).

Subbiah, V; Kreitman, RJ; Wainberg, ZA; Cho, JY; Schellens, JNM; Soria, JC; Wen, PY; Zielinski, C; Urbanowitz, G; Mookerjee, B; Wang, D; Rangwala, FA; Keam, B

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索